PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-2.72%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$84.2M
AUM Growth
+$84.2M
(-11%)
Cap. Flow
-$1.76M
Cap. Flow
% of AUM
-2.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
$1.76M |
Sector Composition
| 1 | Healthcare | 88.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cartesian Therapeutics
RNAC
$261M
| $33M | 39.17% |
1,924,151
| – | – |
|
|
TRVN
2
DELISTED
Trevena, Inc.
TRVN
| $12.1M | 14.33% |
2,053,540
| – | – |
|
|
TTOO
3
DELISTED
T2 Biosystems, Inc
TTOO
| $9.87M | 11.71% |
1,875,524
| – | – |
|
|
GNCA
4
DELISTED
Genocea Biosciences, Inc.
GNCA
| $8.11M | 9.63% |
1,968,606
| – | – |
|
|
5
Ocular Therapeutix
OCUL
$2.12B
| $6.6M | 7.84% |
788,723
-209,990
| -21% | -$1.76M |
|
6
Fate Therapeutics
FATE
$120M
| $6.21M | 7.37% |
2,473,186
| – | – |
|
|
ATYR
7
aTyr Pharma
ATYR
$527M
| $3.93M | 4.66% |
1,827,992
| – | – |
|
8
Dare Bioscience
DARE
$27.2M
| $2.33M | 2.76% |
3,287,529
| – | – |
|
9
Pulmatrix
PULM
$18M
| $2.13M | 2.53% |
3,607,996
| – | – |
|